A double-blind, double-dummy, randomized controlled, multicenter trial of 99Tc-methylene diphosphonate in patients with moderate to severe rheumatoid arthritis.

Chin Med J (Engl) · 2021 · PMC8213301 · PMID 34039871

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

At the end of week 48, although there was a trend toward higher ACR20 and ACR70 in the MTX plus 99 Tc-MDP combination group than in the MTX monotherapy group, the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.